Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Healthcare Executives Challenged to Prioritize Human Experience


“In a focus on human experience, patient, workforce and community commitments are united under an integrated strategy. A human experience lens is a strong foundation on which to build any experience structure.”

The Beryl Institute releases “The Human Experience Imperative: Practical insights for executives on organizational strategy, structure and impact,” identifying the critical reasons today’s healthcare leaders must invest in experience leadership and structure. The paper probes the results from 42 participating organizations in a 50-item survey about items such as leadership roles, department range, intra- organization collation and engagement of patient and family advisors. The paper highlights the impact and reach of dedicated experience efforts on patient outcomes and the human experience in healthcare.

Key takeaways include:

  • An investment in experience leadership and structure is a must.
  • An experience leader should reside in the C-suite (or have direct access to it).
  • An experience office must have operational accountability and reach.

“Leaders today know that the pursuit of the best human experience is a comprehensive effort that ultimately reflects and predicts their organization’s quality, safety, culture, reputation, financial success and long-term viability,” said Jason Wolf, President & CEO of The Beryl Institute. “In a focus on human experience, patient, workforce and community commitments are united under an integrated strategy. A human experience lens is a strong foundation on which to build any experience structure.”

Authors of the paper include members of The Beryl Institute’s Experience Leaders Circle:

  • Brian Carlson, Vice President, Patient Experience, Vanderbilt University Medical Center
  • Jennifer Carron, Patient Experience Officer, BJC Healthcare
  • Julie Kennedy Oehlert, DNP, RN, Chief Experience and Brand Officer, ECU Health
  • Tony Padilla, Vice President, Patient Experience, City of Hope
  • Jason Wolf, PhD, CPXP, President & CEO, The Beryl Institute

To access the executive brief, PX paper, and patient reflection visit https://www.theberylinstitute.org/page/PXPapers

###

About The Beryl Institute

The Beryl Institute is a global community of healthcare professionals and experience champions committed to transforming the human experience in healthcare. As a pioneer and leader of the experience movement and patient experience profession for more than a decade, the Institute offers unparalleled access to unbiased research and proven practices, networking and professional development opportunities and a safe, neutral space to exchange ideas and learn from others.

We define the patient experience as the sum of all interactions, shaped by an organization’s culture, that influence patient perceptions across the continuum of care. We believe human experience is grounded in the experiences of patients and families, members of the healthcare workforce and the communities they serve.

Share article on social media or email:

Regional Health Network contracts Taylor Reach to establish a centralized patient scheduling center


“With a growing population, and increasing demands on the healthcare systems, optimizing patient scheduling can be a key element in improving efficiency as well as the patient experience.” Colin Taylor, Taylor Reach Group

The Taylor Reach Group has been contracted to aid in establishing an appointment-scheduling contact center for a large regional health network in Canada.

Taylor Reach; an award-winning industry leader in Call and Contact Center operations; has been called upon to help design and support the establishment of the health network’s patient scheduling call center operation.

“With a growing population, and increasing demands on the healthcare systems, optimizing patient scheduling can be a key element in improving efficiency as well as the patient experience,” says Taylor Reach CEO Colin Taylor. “With a regional network like this, patients can be expected to attend clinics in several sites for various appointments and procedures. Having that system integrated into a central operation just makes sense.”

Taylor Reach will be working with the key stakeholders in the group, which includes several hospitals and specialized clinics across the urban region. Once factors like appointment volume, scheduling, cancelations and rescheduling are taken into account, a detailed plan can be developed regarding the size of center needed, the number of staff required to support the center and the technology requirements that will underpin the operation.

Taylor Reach has experience working with government, NGO, public services, and health services, within North America and internationally. Our consulting operations have also helped retailers, Fortune 500 companies, and a number of important social services to improve their Contact Center operations. Through a comprehensive examination of the people, processes, technologies, and methodologies employed in any center, we’re able to focus on specific trouble spots and recommend exactly the improvements needed to optimize the support experience.

An independent global Contact Center, Call Center, and Customer Experience consulting and advisory firm established in 2003, Taylor Reach is dedicated to assisting clients to solve customer experience, contact center, and customer service challenges. Services include Strategic Assessments, Training Development, technology acquisition, AI, Revenue Generation, and anything related to optimizing the Contact Center. Taylor Reach serves client organizations across all verticals with anywhere from 5 to 24,000+ agents: SMB’s, Fortune 500, and Global 1000 firms.

Media Contact: For more information on The Taylor Reach Group, Inc. visit https://thetaylorreachgroup.com or phone Steve Baric at 1-866-334-3730 ext. 112

Share article on social media or email:

NuEra Cannabis and Two Brothers Artisan Brewing Collab On CBD-Infused Sparkling Beverage


Riseau canned CBD beverage

“It’s truly remarkable what we have created here. There really is nothing that tastes as special as RisEau on shelves today,” said Jason Ebel, owner of Two Brothers Artisan Brewing Co.

Chicago-based NuEra Cannabis and Two Brothers Artisan Brewing Co. have joined forces to launch RisEau, a new full-flavor, CBD-infused sparkling beverage with 20 mg CBD, just five calories and no artificial sweeteners.

RisEau is available online for $12.49 per four-pack and will soon be available in select retailers in Chicago and Phoenix. RisEau-based cocktails are now being served at The Craftsman Cocktails + Kitchen in Scottsdale, Ariz. The beverage will debut in other key markets later this year, and is available in three bold and natural fruit flavors:


  • Blood Orange: Made with a variety of oranges that is extra sweet with notes of raspberry, grapefruit, and strawberries
  • Hibiscus Berry: Crafted with real hibiscus petals, the flavor is fruity and a touch floral, with ever-so-slightly tart hibiscus and sweet berries
  • Lime & Ginger: Strong notes of ginger and lime create a punchy flavor that is a little spicy and a little sour

RisEau is aptly named for the natural calming effect that the 20 mg of CBD in each can delivers allowing one to “rise” above the chaos and noise of the day, and for the French word for water, eau, an important ingredient to our overall physical well-being. It is also gluten free and caffeine free, and all CBD used in RisEau is pure, stable, totally tasteless and 100% hemp derived.

“After a lot of dreaming, designing, sourcing the highest quality ingredients, and most importantly tasting, our first cases of RisEau have hit the warehouse and we’re thrilled with the end result,” said Laura Jaramillo Bernal, co-founder of RisEau. “The delicious flavor profiles of our first three creations are a huge departure from what currently exists in the market.”

The collaboration between the two Chicago-grown, family-owned companies has been a long time coming. Along with its passion for flavor, manufacturing know-how, and commitment to environmental best practices, Two Brothers also brings decades of expertise in the beverage industry. The nationally-known brand distributes its popular craft beers, spirits and coffee across the country, and owns and operates several restaurants in Illinois and Phoenix.

NuEra is one of the original Illinois cannabis companies. With dispensaries, grow facilities and processing capabilities in multiple states, the NuEra team brings a deep knowledge of the hemp and cannabis plants, from seed to sale, to every can of RisEau.

A long-time friendship between the founders of both businesses along with a shared passion for creating delicious product experiences inspired RisEau. The two companies began working on the concept just over a year ago.

“It’s truly remarkable what we have created here. There really is nothing that tastes as special as RisEau on shelves today,” said Jason Ebel, owner of Two Brothers Artisan Brewing Co. “Plus, it’s extremely effective. It’s a great beverage option for those looking to make healthier choices in 2023. We can’t wait to build a community of RisEau fans and get to work on more delicious flavors.”

To purchase RisEau or get more product information, visit http://www.riseau.com, and follow on Instagram at @drinkriseau. To request RisEau at your local neighborhood market or favorite restaurant, visit https://riseau.com/pages/press and fill out the contact form.

About RisEau

RisEau is a new full-flavor, CBD-infused sparkling beverage with 20mg CBD, just five calories per can and no artificial sweeteners. Crafted as part of a collaboration between two long-standing Chicago family businesses, Two Brothers Artisan Brewing & NuEra Cannabis, RisEau is initially available in three distinct flavors and is sold online at http://www.riseau.com.

Share article on social media or email:



Revere Health reduces Medicare spending by more than $7.2 million in 2021


Revere Health, the largest physician-owned network of multispecialty healthcare clinics in Utah, continued its strong track record of reducing healthcare spending by saving its Medicare patients more than $7.2 million in 2021. This is according to data recently released from the Centers for Medicare & Medicaid Services (CMS) for the 2021 performance year.

Revere Health participates in the federal government’s Medicare initiative known as the Accountable Care Organization (ACO) Model and has achieved savings for seven consecutive years for its Medicare patients in Advance Payment Models (APM). ACOs are groups of hospitals, physicians, and other healthcare providers that join together to better coordinate care. Revere Health also works with many commercial payers and implements the same quality and cost-savings efforts for all its patients.

These savings are calculated based on the expected costs a patient would have incurred if the same care would have been provided by another health system in the state of Utah. Overall, Revere Health has achieved a total gross savings of approximately $73 million since 2015.

“Our consistency in attaining savings for seven consecutive years is a testament to our values, our approach to care, and our people,” said Revere Health CEO Scott Barlow.

According to the ACO performance report for 2021, Revere Health ranked in the top 10 across participating ACOs in the following measures:

  • Stewardship of Patient Resources
  • Access to Specialists
  • Shared Decision Making

As the first Accountable Care Organization accredited by Medicare in Utah, Revere Health is a leader in value-based care, which focuses on improving scientific measurements of health outcomes, improving the patient experience, and lowering overall costs care.

“The future of healthcare lies in value,” Barlow said. “Value-based care allows us to save patients money and curb rising healthcare costs while at the same time provide high-quality, patient-centric care that results in the best outcomes.”

Revere Health will participate in CMS’s newly created ACO REACH program in 2023, which continues the journey of better care at lower costs and adds a focus on addressing health disparities among specific populations.

“By focusing on equity and social determinants of health as part of ACO REACH, we will further improve our ability to care for all patients and obtain a greater understanding of the hinderances that prevent patients from achieving optimal health,” said Revere Health President and Cardiologist Scott Bingham, MD.

About Revere Health

Revere Health is the largest physician-owned network of multispecialty healthcare clinics in Utah and employs more than 200 physicians and 200 advanced practitioners across 30+ medical specialties. Founded in 1969, Revere Health has grown to include more than 100 clinics in both urban and rural areas throughout Utah and Nevada. Revere Health providers offer complete healthcare at every stage of life and have a vested interest in keeping patients healthy, reducing costs, and acting as a true healthcare partners. Revere Health providers strive to offer compassionate, evidence-based care and keep the communities in which they live and practice healthy and thriving. Revere Health’s mission of “your health above all else” is accomplished by delivering the right care at the right time in the right place.

Share article on social media or email:

149 Bio announces acquisition of clinical stage integrin activator program from Gossamer Bio


149 Bio, LLC, a clinical-stage therapeutics company focused on developing breakthrough treatments for kidney diseases and other immune conditions with high unmet need, announced today that it has acquired GB1275, a first-in-class orally bioavailable integrin activator, and the associated CD11b program in its entirety from Gossamer Bio, Inc.

The company plans to advance GB1275 in multiple therapeutic indications, including Lupus Nephritis (LN). GB1275 has the potential to reduce innate immune cell driven autoimmunity in multiple therapeutic areas and significantly improve patients’ lives. It is the first of its kind integrin activator to have entered the clinic.

“Over-exuberant innate immune cell response incites autoimmunity and end-organ injury in multiple autoimmune diseases, such as Systemic Lupus Erythematosus (SLE) and Lupus Nephritis. Targeting key integrin receptor CD11b via the highly novel integrin activator GB1275 has been shown to significantly reduce myeloid cell activity in circulation and leukocyte infiltration in tissues, thereby reducing autoimmune damage,” said 149 Bio founder and CEO Vineet Gupta, PhD.

He continues that, “the acquisition of GB1275 and associated CD11b program, a potentially transformative therapeutic mechanism for autoimmune diseases and other indications, is consistent with our strategy to develop highly differentiated therapeutics to target integrin receptors in a variety of disease areas. We are especially focused on developing novel therapeutics for kidney diseases, to improve care for patients with urgent, unmet needs in these areas.”

The terms of the agreement were not publicly disclosed.

About 149 Bio, LLC

149 Bio is a privately held therapeutics company that is focused on targeting integrin receptors with a highly differentiated mechanism of action – allosteric activation. The company is leveraging pioneering discoveries of its co-founder Vineet Gupta, PhD, who was among the first to develop allosteric activators of integrins. Dr. Gupta’s research has shown that this is a highly differentiated therapeutic modality for targeting integrins. The company has also developed a proprietary CellStaple platform that enables discovery and validation of novel candidates. The company is using this platform for rapid identification and development of allosteric agonists against multiple different integrin targets and has a pipeline of different therapeutic programs in various stages of development.

Investor and Media Contact:

Santiago Balza Pineda

149 Bio, LLC

media@149bio.com

Share article on social media or email:

Mobile Physician Associates Celebrates Over 65,000 In-Person and Virtual Medical Visits, Reinforcing Their Role as the Leader in Mobile Healthcare


Beverly Hills, California – Mobile Physician Associates, the largest physician-owned and operated completely mobile group medical practice in Los Angeles County, Northern Orange County and the Antelope Valley, is proud to announce that they have reached a significant milestone, surpassing 60,000 in-person and virtual medical visits. Led by Founder and Medical Director, Alex Foxman, M.D., F.A.C.P., the company provides exceptional care to the frail, elderly, and disabled population of Los Angeles County, Northern Orange County and the Antelope Valley. Using skilled medical providers, proprietary technology, data analytics, value-based modeling, mobile ancillary services, and over 100 years of combined experience, they bring modern medical care to the comfort of the patients’ homes, assisted living, or any community setting.

At Mobile Physician Associates, their goal is to improve patient outcomes while reducing overall medical spending. Their innovative team based approach has led to a reduction in emergency room, hospital, and skilled nursing facility utilization, which results in significant cost savings for patients and their families. In addition, they have a very high level of patient, family, and caregiver satisfaction.

“With a rapidly aging population, rising healthcare costs, and long emergency room wait times, we have proven that our mobile medical model meets the “Triple Aim” for Medicare and other insurers which includes improving patient care, reducing healthcare costs, and improving population health,” said Dr. Foxman. “We also accept Medicare and other insurances, ensuring that our patients receive the care they need, when they need it.”

Mobile Physician Associates’ mobile ancillary services include mobile lab, immunizations, ultrasounds, x-rays, and more, making it easier for patients to receive the medical care they need without having to leave their homes. The company’s use of proprietary technology and data analytics allows them to provide personalized care and treat patients in a way that is unique to their individual needs.

To learn more about Mobile Physician Associates and their innovative approach to mobile medical care, visit their website at http://www.mymobilephysician.com.

About Mobile Physician Associates Mobile Physician Associates is a physician-owned and operated mobile medical practice based in Beverly Hills, California. With over 100 years of combined experience, the company specializes in providing high-quality medical care to the frail, elderly, and disabled population in Los Angeles County, Northern Orange County and the Antelope Valley. Using a unique combination of skilled medical providers, proprietary technology, data analytics, value-based modeling, mobile ancillary services, and personalized care, Mobile Physician Associates brings the modern doctors’ office to the patients’ homes, assisted living, or any community setting.

The company is dedicated to improving patient outcomes while reducing overall medical spending, and they accept Medicare and other insurances. For additional information or to schedule an interview with Dr.Alex Foxman or a representative from Mobile Physician Associates, please contact:

Name: Michael Simon

Title: General Manager

Phone: (310) 256-2426 ext 250

Email: info@mymobilephysician.com

Share article on social media or email:

Bridgeway Benefit Technologies Executes Long-Term CEO Succession Plan


Todd Plesko

Todd Plesko, CEO Bridgeway Benefit Technologies

It has been my privilege and joy to work with the employees of Bridgeway and to set a direction for the company based on the foundational culture of commitment to servicing our customers — Jenny Morgan, Chairman

Bridgeway Benefit Technologies LLC (Bridgeway or the Company), a leading provider of specialized multiemployer benefits administration technology solutions for more than 40 years, today announced Todd Plesko, a software technology veteran, has joined the company as Chief Executive Officer. After a transition period, current CEO, Jenny Morgan, will retire and step down to serve as Chairman of the Board as part of Bridgeway’s long-term succession plan. Under Plesko the Company is positioned to continue to grow and scale its comprehensive suite of technology services to the multiemployer sector.

After conducting a nationwide search for Bridgeway’s next CEO, Morgan and the Board of Directors cited Plesko’s deep software industry experience and strong leadership abilities as key attributes that will enable him to guide Bridgeway through its next evolution as the foremost technology provider in the Taft-Hartley benefits administration market. “When I met Todd and heard him speak about his passion and experience working with customers and staff to grow and scale software businesses, I knew he was the right person for Bridgeway. Todd is both decisive and personable which is a great combination for a leader in this market. We are thrilled to have him on board, and I am confident that the company is in good hands with Todd and the team at Bridgeway,” said Morgan.

“I am truly honored to serve as CEO at such a well-respected and successful company with a long history of strong employee, customer and partner relationships. Jenny and the executive team have laid a great foundation for Bridgeway, and I look forward to continuing that record of performance. I feel my technical and product background in delivering software solutions to end users will serve Bridgeway customers well as we continue to deliver the highest value to the Taft-Hartley market. I am tremendously excited to lead Bridgeway and eager to dive in and begin a wonderful new adventure as part of the Bridgeway team,” said Plesko.

Plesko brings a 27-year career to Bridgeway as CEO of several software-as-a-service companies ranging from start-up to mature growth-oriented organizations. He has deep expertise in healthcare software, including provider solutions, supply chain, integration and middleware, and clinical communications solutions. Raised in the Midwest by a blue-collar union family, Plesko’s personal roots have bolstered his commitment to organized labor and supporting its members and families. He holds a bachelor’s in economics from Central Michigan University and an MBA from Indiana Institute of Technology.

Morgan, served as CEO of basys LLC for 13 years and most recently guided the Company through the successful merger of basys and Innovative Software Solutions (ISSI) Inc to form Bridgeway Benefit Technologies in 2022. During her tenure she established and expanded the product roadmap highlighted by significant capabilities for automating the benefit administration process and enhancing member services, championed enterprise-wide data security through the implementation of a SOC2 (Service Organization Control 2) compliant hosting environment and doubled the size of the Company’s workforce to support its growing client base and expanded service capabilities.

Morgan will remain employed as an Executive Advisor during the transition to ensure continuity of leadership and become its next Chairman of the Board, where she will focus on strategic planning and corporate development and continue to provide her knowledge and experience to the management team.”

Jenny’s leadership has been a key component of Bridgeway’s success and continued growth. Her vision and mission to bring customers the best possible multiemployer benefits administration technology solutions continues with Todd. His background driving performance and leading technology organizations to achieve long-term objectives firmly positions Bridgeway to build on a proven track record of operational excellence and dedication to customer satisfaction,” said Bridgeway’s Executive Vice President Jeff Herman.

“It has been my privilege and joy to work with the employees of the combined Bridgeway and to set a direction for the company based on the foundational culture of commitment to servicing our customers with exceptional quality and integrity in all we do. Given the Company’s successful history, culture and continued leadership excellence, Bridgeway is poised to thrive with Todd as the CEO and further our mission of developing cost-effective, sustainable and innovative benefit administration solutions in the years ahead,” said Morgan.

About Us: Bridgeway Benefit Technologies is the foremost provider for multiemployer benefits administration technology solutions. With the strength of our BASYS and ISSI platforms, we offer greater choice, enhanced capabilities and unmatched service delivery built for data security, regulatory compliance and a lower cost of ownership. Our software suites, web-based portals and hosting solutions serve the Taft-Hartley community and its millions of union members in the United States and Canada. The company provides trust fund offices, multiemployer plans and third-party administrators with a robust product suite for managing contributions, eligibility, claims processing, retirement plan administration and more. Visit https://www.bridgewaybentech.com.

Share article on social media or email:

Spring-Forward, Fall-Back Daylight Savings Adverse Effects Worsened by Blue-Enriched LED Lights


Dr. Martin Moore-Ede

“The effects of choosing permanent Daylight Savings Time versus permanent Standard Time should not be underestimated,” said Dr. Martin Moore-Ede, director of the Circadian Light Research Center and a leading expert on the effects of light on circadian rhythms.

When the clocks are adjusted forward for Daylight Saving Time on March 12th, over 300 million Americans will rise an hour earlier. While this may sound like a minor event, it is not. Not only will people lose sleep, but their disrupted circadian rhythms will cause many health impacts. Each year, as people try to adjust, heart attacks increase by 17-24%, older patients have 20% more strokes and a 6% rise in fatal traffic accidents. Daylight Savings plays havoc in part due to the increased exposure to indoor lighting. Changing the time people see light affects their circadian rhythm more with the increased usage of blue-enriched LEDs.

People’s exposure to light directly affects their circadian rhythms. That simple one-hour time shift during daylight saving time results in less exposure to daylight in the morning and greater exposure to evening electric light relative to typical sleep and work schedules. As a result, people tend to go to bed and fall asleep later, resulting in chronic sleep loss.

Recently, the Circadian Light Research Center released the results of a consensus survey of 248 leading scientists, which confirms that human circadian clocks are highly sensitive to blue wavelengths, and exposure to insufficient daytime blue-rich light and excessive blue-rich light at night, leads to many major health disorders.

Martin Moore-Ede, M.D., Ph.D., director of the Circadian Light Research Center and a former professor at Harvard Medical School, is the lead author on the study titled Lights Should Support Circadian Rhythms: Evidence-Based Scientific Consensus. It reports there was a scientific consensus on the following:

  • Robust circadian rhythms are essential for maintaining good health
  • Disrupting circadian rhythms can cause ill health.
  • Repetitive and prolonged exposure to light at night bright enough to cause circadian disruption increases the risk of breast cancer in women, increases the risk of obesity and diabetes and increases the risk of sleep disorders


Congress and many states are moving to end this yearly disruption. The US Senate voted unanimously in 2022 to leave the clocks on Daylight Savings Time year-round in the “Sunshine Protection Act.” And if approved by the House of Representatives and President, after March 12th, 2023, the clocks would never be set back to winter standard time.

But not so fast. Permanently setting the clocks earlier by an hour can have a devastating effect on health and economic well-being.

Studies involving millions of Americans living in counties located either just west or just east of a time zone boundary, show significant differences in health.

“The effects of choosing permanent Daylight Savings Time versus permanent Standard Time should not be underestimated,” said Dr. Martin Moore-Ede, director of the Circadian Light Research Center and a leading expert on the effects of light on circadian rhythms. “Living on the western edge of a time zone, where daylight extends an hour more into the evening, and daylight arrives an hour later in the morning reduces the amount of sleep people get, and increases the rate of obesity, diabetes, heart disease and breast cancer, as compared to living on the eastern side of the same time zone. If those living on the western side of a time zone just moved their home a few miles west into the eastern part of the neighboring time zone (or the time zone border was shifted eastwards), their health and economic prospects would radically improve.”

Daylight Savings and Social Jet-Lag

The light of dawn travels at over 700 miles an hour across the USA from east to west. Since the US time zones are 700 – 900 miles wide, the eastern edge of each time zone sees the first light of dawn an hour or more before dawn reaches the western edge of the same time zone. Yet people in a time zone live with the same social, school and work schedules. Extensive studies looking at the health of people living in the counties on each side of the US time zones show a consistent social jet-lag effect of being forced to get up an hour earlier in the morning relative to natural dawn.

Permanent daylight savings time would force the whole population into the plight of the people currently living on the western border of time zones, leading to the health of the western border people getting even worse.

A better option is permanent standard time, which still leaves a disparity between the western and eastern portions of each time zone. The best answer is to adjust social, school and work schedules to be more in tune with the actual timing of dawn and dusk in each locality—that way, the problems of social jet lag can be addressed.

Dr. Moore-Ede offers practical ideas to fend off the effects of Daylight Savings.

TIPS FOR SPRING DAYLIGHT SAVINGS TIME ADJUSTMENT

  • Make an extra effort to get enough sleep
  • Take a nap on the Saturday afternoon before the Daylight Savings change
  • Gradually change bedtime
  • Go to bed 15 minutes earlier each day over the prior three days
  • Wake up 15 minutes earlier each day over the prior three days
  • Get as much morning daylight as you can
  • Go for an early morning walk
  • Adjust your meals to help you adapt
  • Gradually shift the time of meals over the prior three days
  • Take extra care when doing dangerous activities
  • Be extra careful when driving
  • Be cautious when using dangerous equipment


To learn more about circadian rhythm and light visit The Circadian Light Research Center.

About Martin Moore-Ede M.D., Ph.D.

For over 40 years, Dr. Moore-Ede has been a leading world expert on circadian clocks and the health problems caused by electric light at night. As a professor at Harvard Medical School (1975 – 1998), he led the team that located the suprachiasmatic nucleus, the biological clock in the human brain that controls the timing of sleep and wake. He pioneered research on how circadian clocks regulate the timing of body functions. Since 2010, he has led the Circadian Lighting Research Center team that identified the key blue signal that synchronizes circadian clocks and developed patented LED lights, which provide circadian-optimized light across day and night based on comprehensive medical research. The effectiveness of these circadian-modulated lights in improving health and well-being has been validated by installing them in the 24-hour operations of Fortune 500 companies and hospitals. He has published over 180 scientific articles and authored ten books, including the best-selling books, The Clocks that Time Us, and The Twenty-Four Hour Society and he has a forthcoming book The Light Doctor: The Science and Solutions for Replacing Your Lights Now to Protect Your Health. For more information visit, https://thelightdoctor.com.

Share article on social media or email:

Dolphins with Nonalcoholic Fatty Liver Disease May be Key to Finding Its Cure


News Image

A decade ago, few people had heard of a condition called nonalcoholic fatty liver disease, also known as NAFLD. Fast forward to today and 1 in 3 people suffer from this chronic metabolic liver disease, including 1 in 10 children. And yet, there are still no FDA-approved drugs to treat NAFLD.

NAFLD is a leading cause of liver transplants and liver cancer, including in children. While there have been a decade of hypotheses as to how NAFLD emerged this rapidly, an unlikely population may be providing the answer – nutritional deficiencies in an essential nutrient called C15:0 (pentadecanoic acid).

While working to support the long-term health of Navy dolphins for over a decade, veterinary epidemiologist Dr. Stephanie Venn-Watson and others noticed that there “were increasing cases of dolphins with elevated liver enzymes, detected during their routine health exams. When we looked at archived liver tissue samples under the microscope, we surprisingly found that more than 1 out of 3 dolphins had fatty liver disease.”

After publishing these findings in 2013, Dr. Venn-Watson, now co-founder and CEO of Seraphina Therapeutics, was contacted by Dr. Jeffrey Schwimmer, a gastroenterologist at Rady Children’s Hospital in San Diego, and the world’s leader in the understanding and management of pediatric NAFLD. For the past 10 years, Drs. Venn-Watson and Schwimmer have been working in parallel to understand the mechanisms of NAFLD in dolphins and humans, with the hope of finding a cure.

In her work, Dr. Venn-Watson discovered that the healthiest dolphins had higher levels of C15:0 compared those who had chronic metabolic conditions, including fatty liver disease, suggesting that C15:0 may be a key nutrient needed to protect dolphins’ liver health. Dr. Venn-Watson’s surprising discovery of C15:0’s importance was recently highlighted in a New York Times Science feature article and is a TEDx talk.

To test her hypothesis––C15:0 as a liver-protective nutrient––Dr. Venn-Watson conducted eight studies over three years, in which her team demonstrated that C15:0 is a beneficial fatty acid that could slow the advancement of NAFLD. Specifically, Dr. Venn-Watson’s research showed that:

Concurrently, Dr. Schwimmer had completed an independent and extensive study including 237 children, which showed that patients with higher C15:0 blood levels had less fat in their liver. Along with Dr. Schwimmer, research teams from the MD Anderson Cancer Center have shown that higher C15:0 is linked to a lower risk of severe NAFLD.

While humans’ primary dietary source of C15:0 is whole fat cow’s milk and butter, intake of these foods has declined precipitously over the past 40 years as consumers have opted for plant-based milks, which contain no C15:0. As a result, population wide C15:0 levels have been declining. To add to this issue, the amount of C15:0 in whole fat cow’s milk is dependent on what cows are fed, and even types of grasses fed to cows can meaningfully impact whether their milk has adequate C15:0 levels. The risk of nutritional C15:0 deficiencies has increased further among aging populations, since C15:0 levels naturally decline with age, in both humans and dolphins.

In their landmark peer-reviewed publication, Dr. Venn-Watson and Dr. Edward Dennis, a leader in fatty acids and bioactive lipids, laid out evidence supporting C15:0 as an essential fatty acid, making C15:0 the first essential fatty acid to be discovered since omega-3, which was over 90 years ago.

“The timing of populationwide C15:0 nutritional declines coupled with the alarming rise in NAFLD do not appear to be coincidental,” said Dr. Venn-Watson. “The good news is that these nutritional deficiencies can be fixed.”

Today, Dr. Schwimmer is leading a clinical trial at the University of California San Diego to evaluate C15:0’s potential physiological benefits to young adults with a history of NAFLD. This clinical trial is nearing completion, and results are anticipated by the end of 2023. Dr. Venn-Watson is also funded by the Office of Naval Research to further evaluate the health benefits of C15:0 for dolphins with NAFLD.

“We have the Navy’s dolphins to thank for the discovery of C15:0 as an essential fatty acid and a potential means to stem the global rise in NAFLD,” said Dr. Venn-Watson. “It feels even better knowing that this discovery may help children, too.”

******************

About Seraphina Therapeutics. Inc.

Seraphina Therapeutics, Inc. is a health and wellness company dedicated to advancing global health through the discovery of essential fatty acids and micronutrient therapeutics. Through rigorous breakthrough science, the company develops fatty acid supplements, food fortifiers, and nutritional interventions to strengthen cells, keep mitochondria working and advance cellular homeostasis to counter age-related breakdown. With its team of industry-leading scientists, Seraphina Therapeutics challenges long-held approaches to nutrition, enabling the creation of novel health products designed to support quality of life. For more information, please visit DiscoverC15.com and fatty15.com.

Share article on social media or email:

Virtue Technologies Announces Integration with ShipStation


Virtue Technologies, a leading provider of Home Infusion, Specialty Pharmacy, Long Term Care Pharmacy, and Durable Medical Equipment logistics technology solutions, today announced a new partnership with ShipStation, the world’s leading cloud-based ecommerce shipping solution.

The partnership will increase Virtue Technologies’ portfolio of shipping solution offerings for its pharmacy and home medical equipment technology subscribers and address critical, post-acute care delivery needs. Virtue Technologies’ namesake solution, VirtueScript, automates delivery workflow processes and increases the level of communication that occurs across the continuum of post-acute care.

“We’re excited to work with Virtue Technologies,” said Robert Gilbreath, General Manager of ShipStation. “We aim to grant those in the pharmacy and durable medical equipment industries access to optimized delivery management, tracking, and delivery documentation.”

“Partnering with ShipStation allows us to further execute on our vision of taking an agnostic, interoperable approach to healthcare technology solutions,” said Gibran Ameer, Chief Executive Officer of Virtue Technologies. “Our focus remains on reducing friction and offering automation as it relates to delivery management in the post-acute care market. We look forward to leveraging our expertise and applying ShipStation’s shipping knowledge to propel our customers’ businesses collectively.”

The integration is live and available here.

About Virtue Technologies

Virtue Technologies is a provider of cloud-based software committed to solving the challenges of the highly fragmented durable medical equipment and pharmacy markets. The solutions strive to drive out cost and improve the revenue cycle by improving staff efficiency, removing waste, increasing patient satisfaction, and providing unparalleled visibility to pharmacy operations. In an environment of shrinking reimbursements, growing audit risk, and persistent demand from patients and caregivers, Virtue Technologies provides the solutions the market demands.For more information, visit https://www.virtuescript.com.

About ShipStation

Every day, tens of thousands of ecommerce retailers rely on ShipStation to solve the day-to-day challenges of importing orders and processing shipments. The trusted leader in shipping software since its founding in 2011, ShipStation helps online sellers scale their businesses and deliver exceptional customer experiences, with an intuitive online solution that allows them to efficiently ship orders — wherever they sell and however they ship. The multi-channel and multi-carrier platform offers a multitude of integrations, with more than 300 partnerships with leading shopping carts, marketplaces, carriers, and fulfillment services, including USPS, UPS, FedEx, Amazon, Shopify, and BigCommerce. ShipStation is a member of the Auctane family of companies and is headquartered in Austin, TX. Auctane brands include ShipStation, Stamps.com, Packlink, ShippingEasy, ShipWorks, ShipEngine, Endicia, Shipsi, GlobalPost, and Metapack, with offices in Austin, El Segundo, London, Madrid, Sunnyvale, Zielona Gora, and Atlanta. For more information, visit https://www.shipstation.com.

Share article on social media or email: